Regina Holliday's blog is featured (linked) to the right on this page.
Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh
Showing posts with label San Francisco. Show all posts
Showing posts with label San Francisco. Show all posts
Wednesday, February 1, 2012
Regina Holliday and bridging the divide at Health 2.0 2010 San Francisco
Eight minute YouTube on the collision of art and advocacy.

Regina Holliday's blog is featured (linked) to the right on this page.
Regina Holliday's blog is featured (linked) to the right on this page.
Thursday, October 20, 2011
Mercury Fillings are a Failed Implanted Medical Device FiDA
(link) Cautionary YouTube video about mercury toxicity and dental amalgam
FDA Town Hall meetings in Irving, TX 3/10/11 and San Francisco 9/22/11 were attended by speakers on this topic.
FDA Town Hall meetings in Irving, TX 3/10/11 and San Francisco 9/22/11 were attended by speakers on this topic.
Saturday, August 20, 2011
The public is invited (with RSVP) to the microphone!
September 22, 2011 FDA/CDRH Town Hall mtg. in San Francisco
This is an opportunity for the public to attend and support consumer/taxpayer/patient rights in determining how FDA follows up on the IOM 7/29/11 report stating that the 510(k) process is flawed.
Implanted medical devices must be safe and effective: not just "innovative". If you cannot come, please write to :
Dr. Jeffrey Shuren
Director CDRH
Food and Drug Administration (FDA)
9200 Corporate Boulevard
Rockville MD 20859
jeff.shuren@fda.hhs.gov
This is an opportunity for the public to attend and support consumer/taxpayer/patient rights in determining how FDA follows up on the IOM 7/29/11 report stating that the 510(k) process is flawed.
Implanted medical devices must be safe and effective: not just "innovative". If you cannot come, please write to :
Dr. Jeffrey Shuren
Director CDRH
Food and Drug Administration (FDA)
9200 Corporate Boulevard
Rockville MD 20859
jeff.shuren@fda.hhs.gov
Subscribe to:
Posts (Atom)